Sara
Villar Fernández
Colaboradora Clínica
Hospital Vall d'Hebron
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Vall d'Hebron (6)
2024
2023
-
Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC
Acta haematologica, Vol. 146, Núm. 2, pp. 161-165
-
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia
British Journal of Haematology
2021
-
Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial
Blood Advances, Vol. 5, Núm. 3, pp. 760-770
2012
-
Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 6, pp. 1453-1458
-
Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 10, pp. 2479-2486